Exam 2 ID Flashcards
(103 cards)
Recognize word roots of the major structures of the urinary system.
• Major structures • Related combining form
Kidney Nephr/ o, ren/ o
Renal Pelvis Pyel/ o
Urine Ur/ o, urin/ o
Ureters Ureter/o
Urinary Bladder Cyst/o
Urethra Urethr/o
Prostate Prostat/o
Distinguish menarche, menopause and perimenopause.
a. Menarche-beginning of menstrual function
b. Menopause-normal termination of menstrual function
c. Perimenopause-transition phase between regular menstrual periods and no periods at all
Differentiate Type 1 and Type 2 diabetes
a. Type 1-
i. Autoimmune,
ii. Beta cell in pancreas destroyed.
b. Type 2-
i. Insulin resistance
ii. Insulin deficient
Differentiate hyper- and hypothyroidism.
A. Hyperthyroidism-
i. Excessive release of thyroid hormones (T3 and T4)
ii. Accelerated metabolism
B. Hypothyroidism-
i. Increased thyroid stimulation hormone (TSH)
ii. Slowing in physical & mental activity
iii. Weight gain
iv. Cold intolerance
Biguanides
i. MOA
1. Decrease hepatic glucose production
2. Decreases intestinal absorption of glucose
3. Increasing peripheral glucose uptake & metabolism
ii. Drug
1. Metformin (glucophage)
iii. Indications
1. Type 2 diabetes mellitus
2. PCOS
3. Antipsychotic-induced weight gain
iv. Common Adverse Effects
1. Diarrhea, vomiting, weight loss
v. Key Facts
1. Temporarily withhold in patients undergoing radiologic procedures that utilize iodinated contrast.
vi. Patient Counseling
1. Discontinue immediately if have symptoms of lactic acidosis.
(Myalgia, malaise, hyperventilation, unusual somnolence)
Di-Peotidyl Peptidase-4 Inhibitor
i. MOA
1. Increases glucose-dependent insulin secretion
2. Decreases glucagon secretion
3. Decreases hepatic glucose production
ii. Drug
1. Sitagliptin (januvia)
iii. Indications
1. Type 2 Diabetes mellitus
iv. Common Adverse Effects
1. Nausea, diarrhea, vomiting, nasopharyngitis
v. Key Facts
vi. Patient Counseling
1. Discontinue immediately if experience unexplained persistent nausea and vomiting
2. Signs of acute pancreatitis
Insulin
i. MOA
1. Lowers blood glucose
2. Stimulate peripheral glucose uptake
3. Inhibit hepatic glucose production
ii. Drug
1. Insulin
iii. Indications
1. Type 1 diabetes mellitus
2. Type 2 diabetes mellitus
3. Hyperkalemia
4. Diabetic ketoacidosis
iv. Common Adverse Effects
1. Hypoglycemia
2. Anxiety, blurred vision, palpitations, shakiness, slurred speech, sweating
3. Weight gain
v. Key Facts
vi. Patient Counseling
1. Rotate injection site (prevent lipodystrophy)
2. Insulin requirements will increase during times of stress (physical sickness and emotional stress)
3. Treatment of hypoglycemia
4. Mild: treat with oral glucose or simple carbohydrates
5. Can be stored at room temperature
Sulfonylureas
i. MOA
1. Lowers blood glucose
2. Stimulates insulin release from beta cells of pancreas
ii. Drug
1. Glipizide
iii. Indications
1. Type 2 diabetes mellitus
iv. Common Adverse Effects
1. Hypoglycemia
v. Key Facts
vi. Patient Counseling
1. Always eat after taking medication
2. Monitor blood glucose as directed
3. Be aware of signs and symptoms of hypoglycemia
ThIazolidinedIonEs
i. MOA
1. Increase insulin sensitivity
2. Enhance insulin-receptor sensitivity
ii. Drug
1. Pioglitazone (Actos)
iii. Indications
1. Type 2 diabetes metellis
iv. Common Adverse Effects
1. Weight gain, edema, hypoglycemia (when used with insulin or other oral antidiabetic drugs that can cause hypoglycemia)
v. Key Facts
1. Contraindications-NYHA class III and IV heart failure
2. Active liver disease
vi. Patient Counseling
1. Report signs of liver dysfunction and/or shortness of breath immediately
Biphosphonates (jaw)
i. MOA
1. Inhibits osteoclastic-mediated bone resorption
ii. Drug
1. Alendronate
iii. Indications
1. Osteoporosis
2. Paget’s disease
iv. Common Adverse Effects
1. Abdominal pain
2. Diyspepsia
3. Nausea
4. Hypocalcaemia
v. Key Facts
1. Take at least 30 minutes before first food or beverage of day
2. Take with 6 – 8 oz. plain water only
3. Do not lie down for 30 minutes after taking
4. Do not chew or crush
5. Notify healthcare provider if new symptoms of heartburn, difficulty or pain on swallowing develop
vi. Patient Counseling
1. Osteonecrosis of jaw has been observed
Calcitonin-Salmon
i. MOA
1. Directly inhibits osteoclastic bone resorption
2. Decreases renal tubular resorption of calcium, phosphate, sodium, magnesium, and potassium
3. Increase jejunal secretion of water, sodium, potassium, and chloride
ii. Drug
1. Calcitonin
iii. Indications
1. Osteoporosis
2. Paget’s disease
3. Hypercalcemia
iv. Common Adverse Effects
1. Allergic reactions,
2. Nasal mucosal alterations
3. Rhinitis
v. Key Facts
1. Usually used when bisphosphonates are not tolerated
vi. Patient Counseling
1. Prime pump when using new bottle
2. Allow it to be at room temperature before use
3. Store unassembled bottles in refrigerator
4. Once pump activated, store at room temperature for up to 35 days
Glucocorticoids
i. MOA
1. Inhibit cytokines that mediate inflammatory responses
2. Suppress migration of polymorphonuclear leukocytes
3. Decrease capillary permeability
ii. Drug
1. Methylprednisolone/prednisone
iii. Indications
1. Multiple inflammatory conditions
iv. Common Adverse Effects
1. Gastrointestinal irritation,
2. Increased appetite,
3. Nervousness/restlessness,
4. Weight gain,
5. Acne,
6. Glucose intolerance (transient),
7. Lipid abnormalities (transient)
v. Key Facts
1. Contraindications-Systemic fungal infections
2. Contraindications-Administration of concomitant live vaccines
3. Too rapid withdrawal of therapy especially with prolonged use can cause acute, possibly life threatening adrenal insufficiency
vi. Patient Counseling
1. Take oral tablets in morning with food
Thyroid Hormones
i. MOA
1. Synthetic T4
ii. Drug
1. Levothyroxine
iii. Indications
1. Hypothyroidism
iv. Common Adverse Effects
1. Fatigue
2. Increased appetite
3. Weight loss
4. Heat intolerance
v. Key Facts
1. T3 and T4 blood concentrations obtained every 6 – 8 weeks initially, then every 6 – 12 months until stable and annually thereafter.
vi. Patient Counseling
1. Take on empty stomach in the morning at least 30 minutes prior to eating
2. Report any signs or symptoms of thyroid hormone toxicity
3. Chest pain, increased pulse rate, palpitations, excessive sweating, heat intolerance, nervousness
Correctly list the steps of ophthalmic ointment and solution/suspension administration
- Wash hands
- Tilt head back
- Pull lower lid down with index finger
- Apply 0.25–0.5 inch of ointment in sweeping motion inside the lower eyelid
- Close eyes and roll eye in all directions for 1 minute
Do NOT touch medication bottle to eye!
Solution or suspension
- Wash hands
- Tilt head back
- Pull lower lid down with index finger
- Apply medication into conjunctival sac
- Close eyes and apply pressure to lacrimal sac for 1 minute
Define commonly used medication terminology and abbreviations as reviewed in class (ophthalmic)
Ophthalm - eye
Opthamology - Ophthalmology is the branch of medicine which deals with the anatomy, physiology and diseases of the eye.
Ophthalmic - Of or relating to the eye and its diseases.
Miosis - Excessive constriction of the pupil of the eye
mydriasis - Dilation of the pupil of the eye
aqueous humour - aqueous humor: the limpid fluid within the eyeball between the cornea and the lens
conjunctiva - The mucous membrane that covers the front of the eye and lines the inside of the eyelids
blepharitis - Inflammation of the eyelid
cataract - Opacity of the lens or capsule of the eye, causing impairment of vision or blindness.
Ophthalmic Beta Blockers (info)
Mechanism of Action
•Reduces aqueous humor production
•Decreases IOP
Indications
•Glaucoma
•Ocular hypertension
Adverse Effects •Stinging/burning on application •Dry eye •Blepharitis •Corneal anesthesia
Contraindications to Therapy •Asthma/COPD •Bradycardia •Second or third degree AV block •Overt heart failure •Cardiogenic shock
Patient Counseling
•Use proper technique of nasolacrimal occlusion to decrease risk of side effects and increase efficacy
•For ophthalmic use only
•Remove contact lenses prior to use. Do not reinsert for 15 minutes
•Gel solution only:
•Shake once prior to use. Administer other ophthalmic medications at least 12 minutes prior
Ophthalmic Beta Blockers (drugs) ** know them Oll**
•Generic •Brand •Formulation
Timolol Timoptic Solution, Gel forming solution
Timoptic-XE
Betaxolol Betoptic Solution
Carteolol Ocupress Solution
Levobunolol Betagan Solution
Ophthalmic Prostaglandins (drugs) Prost
•Generic •Brand Latanoprost Xalatan Travoprost Travatan Bimatoprost Lumigan, Latisse Tafloprost Zioptan
Ophthalmic Prostaglandins (info)
Mechanism of action
•Increases aqueous humor outflow
•Decreases IOP
Indications
•Glaucoma
Adverse Effects •Increased pigmentation of the iris •Eyelash changes •Eyelid skin darkening •Transient burning and stinging upon instillation •Blurred vision
Neomycin/Polymyxin/Gramicidin
Ophthalmic
Mechanism of Action
•Interferes with bacterial protein synthesis by binding to 30S ribosomal subunits
•Binds to phospholipids and alters permeability of the bacterial membrane permitting leakage of intracellular contents
Indications
•Treatment of superficial infections
Adverse Effects
•Superinfection
•Transient burning, stinging, irritation
Patient Counseling
•For ophthalmic use only
•To avoid contamination, do not touch tip of container to eye or any other surface
Fluoroquinolone’s (drugs) xacin
Ophthalmic
•Generic •Brand •Formulation
Ciprofloxacin Ciloxin Solution, Ointment
Besifloxacin Besivance Suspension shake well before
administering
Gatifloxacin Zymar Solution
Levofloxacin Quixin, Iquix Solution
Moxifloxacin Vigamox, Moxeza Solution
Ofloxacinb Ocuflox Solution
Fluoroquinolone’s (info) xacin
Ophthalmic
Mechanism of Action
•Inhibits the activity of DNA gyrase
•Bacterial DNA is unable to replicate
Indications
•Treatment of superficial ocular infection involving the conjunctiva or cornea
Adverse Effects
•Localized discomfort and irritation
•Transient burning
•Stinging
Patient Counseling
•Do not touch tip of container to eye or any other surface
•For ophthalmic use only
•Remove contact lenses during treatment for conjunctivitis
Estrogen: Estradiol (Estrace)
Estrogen: Estradiol (Estrace)
MOA:
- Developing and maintaining female reproductive system and secondary sex characteristics
- Involved in shaping skeleton and inhibiting bone reabsorption
Indication:
- Treatment of moderate to severe vasomotor symptoms
- Prevention of osteoporosis
Adverse effects:
-vaginal bleeding, breast tenderness, nausea and vomiting
Key facts:
-contraindications: pregnancy, undiagnosed vaginal bleeding, known/suspected breast cancer, severe liver disease
Patient counseling:
- Increase risk of endometrial carcinoma in postmenopausal women
- women with uterus should also should also receive monthly progestins
Progestins: Medroxyprogesterone (Provera, DepoProvera)
MOA:
Inhibit secretion of gonadtropins
Indications:
- Prevention of pregnancy
- abnormal uterine bleeding due to hormonal imbalance
Common adverse effects:
-breakthrough bleeding, nausea
Key facts:
Deep-Provera injection: may lose significan bone mineral density; use as long term birth control method (>2 years) only if other birth control methods are inadequate
Patient counseling:
-progestin withdrawal bleeding occurs within 3-7 days after discontinuing oral therapy